Latest Market Impact News

Telix Pharmaceuticals has secured FDA agreement on a resubmission plan for its glioma imaging agent TLX101-CDx, aiming for a Q4 2025 filing that includes additional efficacy data. The FDA signals likely expedited review, underscoring the unmet medical need.

Pathkey.AI’s TrialKey platform has demonstrated a 73% alignment with actual biotech trial outcomes, showing an average hypothetical share price gain of 76%, underscoring AI’s growing role in clinical trial prediction and biotech investing.

iTech Minerals has responded to ASX concerns, confirming it disclosed material information on its Bayonet, Sabre, and Falchion prospects promptly and in compliance with listing rules.

Cavalier Resources has raised $2.14 million through a discounted placement to fast-track drilling at its Crawford Gold Project, while continuing negotiations for a $11 million pre-payment deal.

ClearVue Technologies has unveiled its Gen3 Solar Vision Glass, achieving a 66% increase in energy output and a 50% reduction in production time and costs, validated by independent testing. This breakthrough positions the company for accelerated commercial adoption in solar-integrated building materials.

PolarX Limited has voluntarily suspended its ASX-listed securities as it finalizes a capital raising, aiming to lift the suspension by 8 September with a market announcement.

Dundee Precious Metals has completed its acquisition of Adriatic Metals through a UK court-sanctioned scheme, leading to Adriatic's delisting and a significant board reshuffle. The deal sets the stage for DPM’s ASX debut with new shares trading from mid-September.

Norwood Systems has refinanced its remaining Balmain loan with a new short-term unsecured facility, eliminating default interest risks and setting clear repayment dates.

St George Mining’s latest drilling assays at the Araxá Project in Brazil reveal exceptional grades of rare earth elements and niobium, signaling a potential major resource upgrade.

Platinum Investment Management has disclosed a significant partial redemption of approximately $580 million by a major client, expected to impact funds under management in October and November 2025.

Orezone Gold Corporation has clarified that it has not received any government request for equity participation in its Bomboré Gold Mine and will resume trading on the ASX. The company also provided updates on its mine expansion and production outlook.

Evolution Energy Minerals has disclosed a default notice from Tanzanian regulators over delayed mining commencement, yet remains confident in retaining its key graphite mining license.